Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-11-21
1988-09-20
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540456, A61K 3133, C07D49812
Patent
active
047725958
ABSTRACT:
Virginiamycin M.sub.1 having the Formula: ##STR1## and virginiamycin M.sub.1 analogs having the Formulae I-IV: ##STR2## Virginiamycin M.sub.1 and the analogs I-IV are antagonists of cholecystokinin (CCK) and gastrin. Cholecystokinin antagonists are useful as analgesics and in the treatment and prevention of disorders of the gastrointestinal, central nervous and appetite regulatory systems in animals, especially humans. Gastrin antagonists are useful in blocking the receptors for gastrin in humans and may function as agents for the treatment of ulcers, tumors or other gastrointestinal disorders. The compounds of Formulae I-IV are also antibiotics and are useful as antimicrobial agents in animals including man and are useful as food additives to promote feed utilization in animals. Virginiamycin M.sub.1 and the analogs of Formula I, III and IV are produced by the controlled aerobic fermentation of a strain of Streptomyces olivaceus, ATCC No. 53527, while the analog of Formula II is produced by chemical synthesis.
REFERENCES:
patent: 2990325 (1961-06-01), Donovick et al.
patent: 3070505 (1962-12-01), Fantes et al.
patent: 3325359 (1967-06-01), De Somer et al.
patent: 4590004 (1986-05-01), Corbet et al.
Chew and Hersey, Am. J. Physiol. 242: G504, (1982).
Cocito, Micro. Rev. 43: 145 (1979).
Faris et al., Science 226: 1215, (1984).
Innis and Snyder, Proc. Natl. Acad. Sci. USA 77: 6917, (1980).
Jensen et al., Proc. Natl. Acad. Sci. USA 77: 2079, (1980).
Kingston et al., J. Chem. Soc. 19: 1669, (1966).
Matsen and Barry, Manual of Clinical Microbiology, Lennette, Spaulding, and Truant, Eds., American Society for Microbiology, Washington DC, p. 418, (1974).
Mutt, Gastrointestinal Hormones, Glass, Ed. Raven Press, N.Y., p. 169, (1980).
Ohyama, Hokkaido J. Med. Sci. 60: 206, (1985).
Praissman et al., J. Receptor Res. 3: 647, (1983).
Prang et al., Ann. Rep. Med. Chem. 17: 31, (1982).
Saito et al., J. Neurochem. 37: 483, (1981).
Smith, Eating and Its Disorders, Stunkard and Steller, Eds. Raven Press, N.Y., p. 67, (1984).
Walsh and Grossman, New Engl. J. Med. 292: 1324, (1975).
Chang Raymond S.
Lam Yiu-kuen T.
Daus Donald G.
Merck & Co. , Inc.
Pfeiffer Hesna J.
Shen Cecilia
Speer Raymond M.
LandOfFree
Synthetic virginiamycin M1 analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic virginiamycin M1 analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic virginiamycin M1 analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1748688